Symbols / IVF Stock $1.44 +1.89% INVO Fertility, Inc.

Healthcare • Medical Devices • United States • NCM
IVF (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Devices
CEO Mr. Steven M. Shum
Exch · Country NCM · United States
Market Cap 2.57M
Enterprise Value 6.25M
Income -7.14M
Sales 6.84M
FCF (ttm) -3.88M
Book/sh -22.34
Cash/sh 1.16
Employees 40
Insider 10d —
IPO Nov 02, 2020
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E -0.18
PEG —
P/S 0.38
P/B -0.06
P/C —
EV/EBITDA -1.21
EV/Sales 0.91
Quick Ratio 0.22
Current Ratio 0.27
Debt/Eq 47.06
LT Debt/Eq —
EPS (ttm) -45.57
EPS next Y -8.00
EPS Growth —
Revenue Growth —
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2025-04-30
Earnings (prior) 2025-04-30
ROA -11.01%
ROE -53.87%
ROIC —
Gross Margin 36.96%
Oper. Margin -89.20%
Profit Margin 0.00%
Shs Outstand 1.79M
Shs Float 1.78M
Insider Own 0.94%
Instit Own 18.29%
Short Float 5.71%
Short Ratio 0.44
Short Interest 92.20K
52W High 183.60
vs 52W High -99.22%
52W Low 1.26
vs 52W Low 13.57%
Beta —
Impl. Vol. —
Rel Volume 0.09
Avg Volume 291.89K
Volume 27.11K
Target (mean) $20.00
Tgt Median $20.00
Tgt Low $20.00
Tgt High $20.00
# Analysts 1
Recom None
Prev Close $1.41
Price $1.44
Change 1.89%
About

INVO Fertility, Inc., a healthcare services company, focuses on the fertility marketplace that provides assisted reproductive technology care to patients. It operates through Fertility Clinic Services; INVOcell Device; and Therapeutics segments. The company offers INVOcell Device, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. It also operates fertility clinics, including INVO Centers. In addition, the company develops NY-303, a GPC3 x NKp46 bifunctional antibody that is in Phase i/ii a monotherapy trial for the treatment of hepatocellular carcinoma; and NY-500, an AI-optimized bifunctional antibody. The company was formerly known as NAYA Biosciences, Inc. and changed its name to INVO Fertility, Inc. in April 2025. INVO Fertility, Inc. was founded in 2007 and is based in Sarasota, Florida.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$20.00
Mean price target
2. Current target
$1.46
Latest analyst target
3. DCF / Fair value
$-39.06
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$1.46
Low
$20.00
High
$20.00
Mean
$20.00
News
RSS: Latest IVF news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2025-12-03 SZOT MATTHEW K Director — 4 $1.52 $6
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
6.84
+4.73%
6.53
+116.25%
3.02
+267.38%
0.82
Operating Revenue
6.84
+4.73%
6.53
+116.25%
3.02
+267.38%
0.82
Cost Of Revenue
4.31
+17.91%
3.66
+89.09%
1.93
+127.37%
0.85
Reconciled Cost Of Revenue
4.31
+17.91%
3.66
+89.09%
1.93
+127.37%
0.85
Gross Profit
2.53
-12.03%
2.87
+164.63%
1.09
+3901.14%
-0.03
Operating Expense
8.37
-6.92%
8.99
+14.48%
7.85
-25.90%
10.60
Research And Development
0.00
-100.00%
0.00
-97.06%
0.17
-69.50%
0.54
Selling General And Administration
7.69
-4.64%
8.07
+7.74%
7.49
-24.96%
9.98
Total Expenses
12.68
+0.26%
12.65
+29.22%
9.79
-14.51%
11.45
Operating Income
-5.84
+4.51%
-6.12
+9.62%
-6.77
+36.32%
-10.63
Total Operating Income As Reported
-7.24
-9.20%
-6.63
+2.06%
-6.77
+36.32%
-10.63
EBITDA
-3.51
+37.88%
-5.65
+17.95%
-6.88
+36.02%
-10.75
Normalized EBITDA
0.04
+100.78%
-5.19
+21.72%
-6.63
+38.35%
-10.75
Reconciled Depreciation
0.68
-26.34%
0.92
+357.76%
0.20
+159.89%
0.08
EBIT
-4.18
+36.26%
-6.56
+7.29%
-7.08
+34.62%
-10.83
Total Unusual Items
-3.55
-675.25%
-0.46
-80.52%
-0.25
-7220.01%
-0.00
Total Unusual Items Excluding Goodwill
-3.55
-675.25%
-0.46
-80.52%
-0.25
-7220.01%
-0.00
Special Income Charges
-2.60
-468.99%
-0.46
-80.82%
-0.25
0.00
Other Special Charges
1.21
+2331.51%
-0.05
-133.11%
0.16
—
Impairment Of Capital Assets
1.40
0.00
—
—
Write Off
—
0.00
-100.00%
0.09
0.00
Net Income
-23.32
-151.90%
-9.26
-15.24%
-8.03
+26.24%
-10.89
Pretax Income
-5.49
+27.81%
-7.60
+5.08%
-8.01
+26.47%
-10.89
Net Non Operating Interest Income Expense
-1.30
-25.79%
-1.04
-11.80%
-0.93
-1465.70%
-0.06
Interest Expense Non Operating
1.30
+25.79%
1.04
+11.80%
0.93
+1457.59%
0.06
Net Interest Income
-1.30
-25.79%
-1.04
-11.80%
-0.93
-1465.70%
-0.06
Interest Expense
1.30
+25.79%
1.04
+11.80%
0.93
+1457.59%
0.06
Interest Income Non Operating
—
—
0.00
-100.00%
0.00
Interest Income
—
—
0.00
-100.00%
0.00
Other Income Expense
1.66
+469.12%
-0.45
-42.96%
-0.31
-53.79%
-0.20
Other Non Operating Income Expenses
5.17
—
—
—
Gain On Sale Of Security
-0.94
—
-0.00
+87.87%
-0.00
Tax Provision
-0.15
-207.25%
0.14
+404.58%
0.03
+867.48%
0.00
Tax Rate For Calcs
0.00
-86.95%
0.00
+0.00%
0.00
+0.00%
0.00
Tax Effect Of Unusual Items
-0.10
-1.18%
-0.10
-80.52%
-0.05
-7220.01%
-0.00
Net Income Including Noncontrolling Interests
-23.32
-151.90%
-9.26
-15.24%
-8.03
+26.24%
-10.89
Net Income From Continuing Operation Net Minority Interest
-5.34
+31.06%
-7.74
+3.67%
-8.03
+26.24%
-10.89
Net Income From Continuing And Discontinued Operation
-23.32
-151.90%
-9.26
-15.24%
-8.03
+26.24%
-10.89
Net Income Continuous Operations
-5.34
+31.06%
-7.74
+3.67%
-8.03
+26.24%
-10.89
Net Income Discontinuous Operations
-17.99
-1084.14%
-1.52
—
—
Normalized Income
-1.89
+74.44%
-7.38
+5.82%
-7.83
+28.06%
-10.89
Net Income Common Stockholders
-25.13
-164.26%
-9.51
-18.36%
-8.03
+26.24%
-10.89
Otherunder Preferred Stock Dividend
1.81
+621.04%
0.25
0.00
—
Diluted EPS
-214.64
+94.33%
-3,782.65
+18.55%
-4,644.28
+82.01%
-25,811.64
Basic EPS
-214.64
+94.33%
-3,782.65
+18.55%
-4,644.28
+82.01%
-25,811.64
Basic Average Shares
0.12
+4557.24%
0.00
+45.32%
0.00
+309.95%
0.00
Diluted Average Shares
0.12
+4557.24%
0.00
+45.32%
0.00
+309.95%
0.00
Diluted NI Availto Com Stockholders
-25.13
-164.26%
-9.51
-18.36%
-8.03
+26.24%
-10.89
Depreciation Amortization Depletion Income Statement
0.68
-26.34%
0.92
+357.76%
0.20
+159.89%
0.08
Depreciation And Amortization In Income Statement
0.68
-26.34%
0.92
+357.76%
0.20
+159.89%
0.08
Earnings From Equity Interest
0.03
+245.98%
0.01
+115.01%
-0.06
+69.95%
-0.20
Gain On Sale Of PPE
0.00
+100.00%
-0.51
0.00
—
Line Item Trend 2023-12-31
Total Assets
18.51
Current Assets
1.26
Cash Cash Equivalents And Short Term Investments
0.23
Cash And Cash Equivalents
0.23
Cash Financial
0.23
Receivables
0.14
Accounts Receivable
0.14
Gross Accounts Receivable
—
Allowance For Doubtful Accounts Receivable
—
Inventory
0.26
Raw Materials
0.05
Work In Process
—
Finished Goods
0.21
Prepaid Assets
—
Assets Held For Sale Current
—
Other Current Assets
0.62
Total Non Current Assets
17.25
Net PPE
4.19
Gross PPE
4.42
Accumulated Depreciation
-0.23
Properties
0.00
Machinery Furniture Equipment
0.09
Other Properties
3.80
Leases
0.54
Goodwill And Other Intangible Assets
9.97
Goodwill
5.88
Other Intangible Assets
4.09
Investments And Advances
3.09
Long Term Equity Investment
3.09
Other Non Current Assets
—
Total Liabilities Net Minority Interest
17.61
Current Liabilities
8.00
Payables And Accrued Expenses
4.83
Payables
4.83
Accounts Payable
2.33
Other Payable
2.50
Pensionand Other Post Retirement Benefit Plans Current
0.72
Total Tax Payable
—
Income Tax Payable
—
Current Debt And Capital Lease Obligation
1.69
Current Debt
1.51
Other Current Borrowings
0.63
Current Capital Lease Obligation
0.18
Current Deferred Liabilities
0.41
Current Deferred Revenue
0.41
Other Current Liabilities
0.35
Total Non Current Liabilities Net Minority Interest
9.61
Long Term Debt And Capital Lease Obligation
4.61
Long Term Debt
1.25
Long Term Capital Lease Obligation
3.36
Tradeand Other Payables Non Current
5.00
Non Current Deferred Liabilities
0.00
Non Current Deferred Revenue
—
Non Current Deferred Taxes Liabilities
0.00
Other Non Current Liabilities
0.00
Preferred Securities Outside Stock Equity
0.00
Stockholders Equity
0.89
Common Stock Equity
-5.11
Capital Stock
6.00
Common Stock
0.00
Preferred Stock
6.00
Share Issued
0.00
Ordinary Shares Number
0.00
Treasury Shares Number
0.00
Additional Paid In Capital
52.71
Retained Earnings
-57.82
Total Equity Gross Minority Interest
0.89
Total Capitalization
2.15
Working Capital
-6.74
Invested Capital
-2.34
Total Debt
6.30
Net Debt
2.53
Capital Lease Obligations
3.54
Net Tangible Assets
-9.08
Tangible Book Value
-15.08
Current Notes Payable
0.88
Investmentsin Joint Venturesat Cost
0.92
Investmentsin Subsidiariesat Cost
2.17
Non Current Note Receivables
—
Preferred Stock Equity
6.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-7.01
-135.83%
-2.97
+37.45%
-4.76
+27.99%
-6.60
Cash Flow From Continuing Operating Activities
-7.01
-135.83%
-2.97
+37.45%
-4.76
+27.99%
-6.60
Net Income From Continuing Operations
-23.32
-151.90%
-9.26
-15.24%
-8.03
+26.24%
-10.89
Depreciation Amortization Depletion
0.68
-26.34%
0.92
+357.76%
0.20
+159.89%
0.08
Depreciation
—
—
—
0.31
Depreciation And Amortization
0.68
-26.34%
0.92
+357.76%
0.20
+159.89%
0.08
Other Non Cash Items
0.39
-67.80%
1.21
+34.02%
0.90
+421.38%
0.17
Stock Based Compensation
1.47
-7.58%
1.59
+14.08%
1.39
-37.35%
2.22
Asset Impairment Charge
16.04
0.00
-100.00%
0.09
-32.09%
0.13
Operating Gains Losses
-0.59
-208.46%
0.54
+142.95%
0.22
+11.46%
0.20
Gain Loss On Investment Securities
-4.23
—
—
—
Gain Loss On Sale Of PPE
0.00
-100.00%
0.51
0.00
—
Change In Working Capital
-1.68
-182.92%
2.03
+329.48%
0.47
-68.17%
1.48
Change In Receivables
-0.10
-479.55%
0.03
+143.28%
-0.06
-137.64%
-0.03
Changes In Account Receivables
-0.10
-479.55%
0.03
+143.28%
-0.06
-137.64%
-0.03
Change In Inventory
-0.01
-112.27%
0.04
+5043.98%
-0.00
-103.74%
0.02
Change In Prepaid Assets
-0.12
+26.43%
-0.16
+62.10%
-0.43
-566.88%
0.09
Change In Payables And Accrued Expense
-1.36
-175.71%
1.79
+117.88%
0.82
-35.24%
1.27
Change In Accrued Expense
-0.03
-107.74%
0.44
+532.16%
-0.10
-127.90%
0.37
Change In Payable
-1.32
-197.93%
1.35
+46.07%
0.92
+2.28%
0.90
Change In Account Payable
-1.32
-197.93%
1.35
+46.07%
0.92
+2.28%
0.90
Change In Other Working Capital
-0.04
-112.22%
0.36
+24.31%
0.29
+149.98%
0.11
Change In Other Current Assets
0.00
-100.00%
0.00
0.00
—
Change In Other Current Liabilities
-0.05
-37.25%
-0.04
+74.60%
-0.14
-2112.20%
0.01
Investing Cash Flow
-2.75
-854.47%
0.36
+114.59%
-2.49
-2971.87%
-0.08
Cash Flow From Continuing Investing Activities
-2.75
-854.47%
0.36
+114.59%
-2.49
-2971.87%
-0.08
Net PPE Purchase And Sale
-0.04
+59.85%
-0.11
+75.69%
-0.44
-4023.52%
-0.01
Purchase Of PPE
-0.04
+76.37%
-0.18
+58.69%
-0.44
-4023.52%
-0.01
Sale Of PPE
0.00
-100.00%
0.08
0.00
—
Capital Expenditure
-0.04
+76.37%
-0.18
+58.69%
-0.44
-3394.04%
-0.01
Net Business Purchase And Sale
-2.70
-672.46%
0.47
+123.02%
-2.05
-2893.41%
-0.07
Purchase Of Business
-2.70
0.00
+100.00%
-2.05
-2893.41%
-0.07
Net Intangibles Purchase And Sale
—
—
0.00
+100.00%
-0.00
Purchase Of Intangibles
—
—
0.00
+100.00%
-0.00
Financing Cash Flow
11.10
+255.71%
3.12
-57.80%
7.39
+578.31%
1.09
Cash Flow From Continuing Financing Activities
11.10
+255.71%
3.12
-57.80%
7.39
+578.31%
1.09
Net Issuance Payments Of Debt
-1.22
-397.63%
0.41
-75.38%
1.66
+108.11%
0.80
Issuance Of Debt
0.00
-100.00%
1.34
-57.46%
3.16
+295.03%
0.80
Repayment Of Debt
-1.22
-30.54%
-0.93
+37.51%
-1.50
0.00
Long Term Debt Issuance
0.00
-100.00%
1.34
-57.46%
3.16
+295.03%
0.80
Long Term Debt Payments
-1.22
-30.54%
-0.93
+37.51%
-1.50
0.00
Net Long Term Debt Issuance
-1.22
-397.63%
0.41
-75.38%
1.66
+108.11%
0.80
Short Term Debt Issuance
—
0.00
-100.00%
0.10
-87.50%
0.80
Short Term Debt Payments
—
—
—
0.00
Net Short Term Debt Issuance
—
0.00
-100.00%
0.10
-87.50%
0.80
Net Common Stock Issuance
12.36
+7382.31%
0.17
-97.10%
5.70
+1867.55%
0.29
Repurchase Of Capital Stock
-4.00
0.00
—
—
Proceeds From Stock Option Exercised
1.11
+23.32%
0.90
+3442.09%
0.03
0.00
Changes In Cash
1.34
+162.58%
0.51
+257.70%
0.14
+102.54%
-5.59
Beginning Cash Position
0.74
+218.98%
0.23
+157.86%
0.09
-98.41%
5.68
End Cash Position
2.08
+180.26%
0.74
+218.98%
0.23
+157.86%
0.09
Free Cash Flow
-7.06
-123.49%
-3.16
+39.26%
-5.20
+21.41%
-6.62
Interest Paid Supplemental Data
0.64
+199.97%
0.21
+2127.61%
0.01
0.00
Income Tax Paid Supplemental Data
0.00
0.00
0.00
-100.00%
0.00
Change In Income Tax Payable
—
—
—
0.00
Change In Interest Payable
0.12
-28.59%
0.17
+36.85%
0.12
+7731.88%
0.00
Change In Tax Payable
—
—
—
0.00
Common Stock Issuance
12.36
+7382.31%
0.17
-97.10%
5.70
+1867.55%
0.29
Earnings Losses From Equity Investments
-0.03
-245.98%
-0.01
-115.01%
0.06
-69.95%
0.20
Issuance Of Capital Stock
15.21
+740.54%
1.81
-68.27%
5.70
+1867.55%
0.29
Net Preferred Stock Issuance
-1.15
-169.96%
1.64
0.00
—
Preferred Stock Issuance
2.85
+73.37%
1.64
0.00
—
Preferred Stock Payments
-4.00
0.00
—
—
Sale Of Business
0.00
-100.00%
0.47
0.00
—
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category